Column Group LLC Q2 2025 Filing

Filed August 15, 2025

Portfolio Value

$65.7B

Holdings

5

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
ORICORIC Pharmaceuticals Inc.
3,540,777$35.9B54.68%
2
SRZNSurrozen, Inc.
1,499,773$13.4B20.40%
3
RAPTEURRAPT Therapeutics Inc
1,328,613$10.6B16.17%
4
TNYATenaya Therapeutics, Inc.
9,400,290$5.7B8.74%
5
RVMDRevolution Medicines Inc
46$1.7M0.00%